Envestnet Inc. (ENV)
| Bid | n/a |
| Market Cap | 3.49B |
| Revenue (ttm) | 1.33B |
| Net Income (ttm) | -261.52M |
| EPS (ttm) | -4.78 |
| PE Ratio (ttm) | -13.209205020920502 |
| Forward PE | n/a |
| Analyst | Hold |
| Ask | n/a |
| Volume | 0 |
| Avg. Volume (20D) | 0 |
| Open | undefined |
| Previous Close | undefined |
| Day's Range | 63.14 - 63.14 |
| 52-Week Range | 63.14 - 63.14 |
| Beta | 1.25 |
About ENV
Envestnet, Inc., together with its subsidiaries, provides wealth management software and services in the United States and internationally. It operates through Envestnet Wealth Solutions and Envestnet Data & Analytics segments. The company's product and services include Envestnet | Enterprise, which provides an end-to-end open architecture wealth management platform, as well as offers data aggregation and reporting, data analytics, and digital ad...
Analyst Forecast
According to 5 analyst ratings, the average rating for ENV stock is "Hold." The 12-month stock price forecast is $63.15, which is an increase of 0.02% from the latest price.
Stock Forecasts
2 months ago · businesswire.com
NewEdge Investment Solutions Now Available on Envestnet, SMArtX PlatformsSTAMFORD, Conn.--(BUSINESS WIRE)--NewEdge Wealth, LLC, a registered investment advisor specializing in serving ultra high net worth families, family offices and institutional clients, announced today ...
2 months ago · businesswire.com
Kairos Pharma Announces New Department of Defense Funding for Research of ENV205LOS ANGELES--(BUSINESS WIRE)--Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company, announces that through its academic partnership with Cedars-Sinai Medical Center, C...